iA Global Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.5M Sell
186,455
-48,242
-21% -$23.2M 1.11% 20
2026
Q1
$115M Buy
234,697
+5,246
+2% +$2.85M 1.63% 10
2025
Q4
$133M Sell
229,451
-13,530
-6% -$7.65M 1.7% 11
2025
Q3
$118M Buy
242,981
+92,871
+62% +$43.2M 1.61% 12
2025
Q2
$60.9M Sell
150,110
-11,445
-7% -$4.79M 0.92% 26
2025
Q1
$80.4M Buy
161,555
+28,081
+21% +$15.2M 1.38% 17
2024
Q4
$69.4M Buy
133,474
+4,393
+3% +$2.42M 1.22% 17
2024
Q3
$79.8M Buy
129,081
+1,425
+1% +$844K 1.4% 17
2024
Q2
$70.6M Sell
127,656
-20,131
-14% -$11.5M 1.35% 16
2024
Q1
$85.9M Sell
147,787
-16,767
-10% -$9.41M 1.76% 13
2023
Q4
$87.3M Buy
164,554
+69,610
+73% +$33.7M 2.02% 10
2023
Q3
$48.1M Buy
94,944
+6,026
+7% +$3.21M 1.27% 19
2023
Q2
$46.4M Buy
+88,918
New +$48M 1.23% 18

Other funds holding TMO

iA Global Asset Management's TMO Position: Q2 2026 in Review

iA Global Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q2 2026, selling an estimated $23.2M and leaving 186,455 shares worth $93.5M. The position accounts for 1.11% of the portfolio, ranked #20.

iA Global Asset Management first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $133M in Q4 2025. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • iA Global Asset Management held 186,455 shares of Thermo Fisher Scientific worth $93.5M as of Q2 2026.
  • iA Global Asset Management sold 48,242 Thermo Fisher Scientific shares in Q2 2026, an estimated $23.2M.
  • Thermo Fisher Scientific made up 1.11% of iA Global Asset Management's portfolio in Q2 2026, its #20 holding.
  • iA Global Asset Management first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • iA Global Asset Management's Thermo Fisher Scientific position peaked at $133M in Q4 2025.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.